Index S&P 500
P/E 8.81
EPS (ttm) 4.04
Insider Own 1.29%
Shs Outstand 491.13M
Perf Week -5.79%
Market Cap 17.50B
Forward P/E 11.73
EPS next Y 3.04
Insider Trans 0.45%
Shs Float 484.80M
Perf Month 11.31%
Enterprise Value -
PEG -
EPS next Q -0.14
Inst Own 98.28%
Short Float 2.78%
Perf Quarter 27.51%
Income 2.05B
P/S 0.10
EPS this Y -76.56%
Inst Trans -1.35%
Short Ratio 0.87
Perf Half Y -42.50%
Sales 178.19B
P/B 0.64
EPS next Y 80.78%
ROA 2.42%
Short Interest 13.47M
Perf YTD -41.17%
Book/sh 55.80
P/C -
EPS next 5Y -13.89%
ROE 7.50%
52W High 70.11 -49.17%
Perf Year -51.11%
Cash/sh -
P/FCF 16.21
EPS past 3/5Y 40.38% 14.96%
ROIC 4.57%
52W Low 25.08 42.13%
Perf 3Y -52.68%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y 8.98% 16.92%
Gross Margin -
Volatility 3.54% 3.39%
Perf 5Y -44.49%
Dividend TTM -
EV/Sales -
EPS Y/Y TTM -23.25%
Oper. Margin 1.12%
ATR (14) 1.27
Perf 10Y 29.74%
Dividend Ex-Date -
Quick Ratio -
Sales Y/Y TTM 12.96%
Profit Margin 1.15%
RSI (14) 53.88
Recom 2.74
Dividend Gr. 3/5Y - -
Current Ratio 1.10
EPS Q/Q -123.74%
SMA20 -0.39%
Beta 0.49
Target Price 34.00
Payout 0.00%
Debt/Eq 0.64
Sales Q/Q 22.36%
SMA50 11.74%
Rel Volume 0.00
Prev Close 35.64
Employees 60500
LT Debt/Eq 0.64
Earnings Oct 29 BMO
SMA200 -26.96%
Avg Volume 15.50M
Price 35.64
IPO Dec 13, 2001
Option/Short Yes / Yes
EPS/Sales Surpr. -243.37% 10.44%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-14-25 Initiated
Goldman
Sell
$33
Jul-28-25 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$38
Jul-23-25 Downgrade
Wells Fargo
Overweight → Equal Weight
$30
Jul-21-25 Downgrade
TD Cowen
Buy → Hold
$33
Jul-16-25 Downgrade
BofA Securities
Neutral → Underperform
$30
Jul-10-25 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$33
Jul-02-25 Downgrade
UBS
Buy → Neutral
$45
Jul-02-25 Downgrade
JP Morgan
Overweight → Neutral
$48
Jun-09-25 Resumed
Morgan Stanley
Overweight
$70
Jun-02-25 Downgrade
Barclays
Overweight → Equal Weight
$65
Apr-08-25 Upgrade
Jefferies
Underperform → Hold
$64
Feb-06-25 Downgrade
Argus
Buy → Hold
Dec-17-24 Resumed
JP Morgan
Overweight
$80 → $75
Dec-13-24 Upgrade
UBS
Neutral → Buy
$79 → $80
Dec-10-24 Downgrade
Jefferies
Hold → Underperform
$68 → $52
Jul-24-24 Downgrade
Jefferies
Buy → Hold
$83 → $69
May-30-24 Initiated
Robert W. Baird
Neutral
$83
Mar-21-24 Downgrade
Stephens
Overweight → Equal-Weight
$92 → $85
Mar-06-24 Initiated
Barclays
Overweight
$101
Jan-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$82 → $90
Show Previous Ratings
Oct-15-25 06:00AM
Oct-14-25 09:44AM
Oct-13-25 08:21AM
Oct-12-25 07:46AM
Oct-10-25 09:40AM
05:43AM
Loading…
05:43AM
Oct-09-25 09:49AM
Oct-08-25 05:01PM
01:44PM
03:00AM
Oct-07-25 09:46AM
(Investor's Business Daily)
Oct-03-25 01:20PM
Oct-02-25 03:50PM
Oct-01-25 02:02PM
11:00AM
09:57AM
Loading…
Sep-29-25 09:57AM
Sep-26-25 08:54AM
Sep-25-25 11:00AM
Sep-24-25 08:00AM
Sep-23-25 07:30PM
09:46AM
Sep-22-25 12:03AM
Sep-18-25 06:21PM
Sep-16-25 01:23PM
Sep-15-25 11:45AM
Sep-12-25 04:01PM
12:26PM
11:18AM
09:00AM
06:13AM
04:54PM
Loading…
Sep-11-25 04:54PM
04:38PM
(The Wall Street Journal)
02:38PM
11:56AM
11:36AM
10:26AM
09:24AM
08:22AM
02:46AM
Sep-10-25 01:40PM
10:29AM
09:25AM
09:00AM
Sep-09-25 04:30PM
09:55AM
Sep-08-25 11:33PM
Sep-05-25 04:02PM
11:12AM
Sep-04-25 02:41PM
02:36PM
Sep-03-25 05:25PM
Sep-02-25 03:35PM
10:38AM
Aug-30-25 10:30AM
Aug-28-25 11:30AM
Aug-27-25 12:50PM
11:00AM
10:31AM
Aug-26-25 04:19PM
11:02AM
08:40AM
07:00AM
Aug-25-25 12:35PM
Aug-21-25 12:20PM
Aug-20-25 05:56PM
05:06PM
01:46PM
Aug-19-25 05:46PM
03:37PM
11:44AM
Aug-18-25 10:30AM
(Associated Press Finance)
09:22AM
08:00AM
(Investor's Business Daily)
Aug-16-25 07:00AM
Aug-15-25 10:00PM
04:37PM
04:04PM
03:06PM
01:56PM
12:13PM
(Investor's Business Daily)
11:33AM
11:29AM
10:16AM
09:02AM
07:17AM
06:24AM
12:42AM
Aug-14-25 12:07PM
Aug-13-25 05:02PM
12:45PM
10:02AM
Aug-12-25 11:38PM
11:32PM
02:20PM
Aug-11-25 12:23PM
Aug-08-25 09:40AM
Aug-07-25 01:02PM
10:51AM
09:00AM
Aug-06-25 09:47AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wayne S DeVeydt Director Oct 15 '25 Proposed Sale 35.84 5,489 196,737 Oct 15 03:29 PM DeVeydt Wayne S Director Sep 09 '25 Proposed Sale 29.19 10,775 314,545 Sep 09 01:55 PM LONDON SARAH Chief Executive Officer Aug 08 '25 Buy 25.50 19,230 490,365 845,275 Aug 11 05:28 PM Samuels Theodore R. II Director Jul 28 '25 Buy 27.62 9,000 248,580 32,000 Jul 29 06:01 PM FASOLA KENNETH J Officer Mar 21 '25 Proposed Sale 59.06 8,500 501,970 Mar 21 10:37 AM Greco Thomas Director Dec 18 '24 Buy 59.75 17,000 1,015,750 19,309 Dec 19 05:39 PM Dallas H James Director Dec 16 '24 Buy 59.01 1,693 99,904 1,693 Dec 17 07:34 PM BLUME JESSICA L. Director Dec 16 '24 Buy 59.48 250 14,870 250 Dec 17 07:33 PM COUGHLIN CHRISTOPHER J Director Dec 16 '24 Buy 59.44 10,000 594,400 36,358 Dec 17 07:33 PM Samuels Theodore R. II Director Dec 13 '24 Buy 58.86 5,000 294,300 23,000 Dec 17 07:33 PM Asher Andrew Lynn Chief Financial Officer Nov 13 '24 Buy 58.14 17,200 1,000,008 486,847 Nov 13 06:07 PM LONDON SARAH Chief Executive Officer Nov 08 '24 Buy 60.80 4,117 250,314 667,229 Nov 08 06:15 PM